Home / HAP Quality Comparison
Quality Reference

Not all hydroxyapatite
performs the same

The INCI name is identical. The functional performance is not. Source material, manufacturing process, and quality standard determine whether a hydroxyapatite ingredient delivers substantiated claims — or simply appears on an ingredient list.

Technical Comparison

Quality beyond the source material

Both general mineral-derived HAP and Hydroxyapatite-LC originate from limestone. The difference is everything that happens after — process control, particle engineering, quality oversight, and application design.

Technical quality comparison: General mineral-derived hydroxyapatite vs Hydroxyapatite-LC. Comparing raw material origin, manufacturing process, particle consistency, quality standard, purity and impurity control, GHS safety profile, designed application, and quality assurance.
Figure 01

The critical difference lies not in the source rock but in the precision of the manufacturing process and the purpose of the design. Functional-grade HAP for cosmetic and oral care requires particle consistency and quality oversight that general industrial-grade material does not provide.

Specification by specification

Eight parameters that determine
formulation performance

Parameter General mineral-derived HAP Hydroxyapatite-LC
Raw material origin Mineral-derived (limestone). Common mineral source, standard global supply. Mineral-derived (limestone), Japan. Same source
Manufacturing process ✗Standardised industrial processes with potential variability between producers. Less precise control over particle outcome. ✓Patented, highly controlled manufacturing process. Stable, repeatable output ensuring uniformity across lots. Patented
Particle consistency ✗Inconsistent particle size and morphology, leading to higher lot-to-lot variation and less predictable formulation performance. ✓Precisely controlled particle size 20–80 nm and morphology for minimal lot-to-lot variation. Consistent sensory and functional performance.
Quality standard ✗General industrial standards. May not be optimised for oral or cosmetic use. Focus on bulk application. ✓Quality design based on Japanese Quasi-Drug Raw Material standards. Specifically optimised for cosmetic and oral care use. Quasi-Drug
Purity & impurity control ✗Management of impurities such as heavy metals can be inconsistent or unclear. May require additional testing before cosmetic use. ✓Rigorous and clearly defined management of impurities, ensuring high purity with strict criteria. Complete lot traceability.
GHS safety profile ✗Safety data may vary. Not always classified with oral or cosmetic use in mind. Potential for classification ambiguity requiring clarification. ✓Confirmed non-hazardous under GHS. Safe and approved for intended cosmetic and oral care applications. Non-hazardous
Designed application ✗Often a general-purpose mineral powder for broad industrial use. Not specialised for personal care performance claims. ✓Specifically designed and optimised for cosmetic and oral care applications. Tailored particle performance. Specialised
Quality assurance ✗Quality control standards vary by country and manufacturer. Less rigorous overall oversight and documentation. ✓100% manufactured and quality controlled in Japan under strict standards. Complete documentation package available. Japan QC
The performance data

Where the difference is measurable

The quality gap between functional-grade and industrial-grade HAP is not theoretical. These figures are from peer-reviewed research comparing material performance in direct tests.

1,974 ppm
Magnesium content in Hydroxyapatite-LC versus approximately 2 ppm in standard synthetic alternatives — a compositional difference with direct consequences for calcium ion release and enamel integration.
BiST Tech mineral analysis data
289%
More bioavailable calcium released by high-magnesium Hydroxyapatite-LC (47.8 mg/L) versus low-magnesium synthetic HAP (12.3 mg/L) at 24 hours — directly determining remineralisation rate at the enamel surface.
University of the Ryukyus, 2024
15 μm
Deep enamel penetration achieved by Hydroxyapatite-LC versus surface coating only in low-magnesium alternatives — the difference between structural reinforcement and surface protection.
University of the Ryukyus, 2024
55%
Superior bone mineral density improvement in the Hydroxyapatite-LC group (32.53%) versus conventional controls (20.95%) in controlled animal studies — demonstrating the bioactive advantage of the richer mineral matrix.
Journal of Functional Biomaterials, 2025
20–80 nm
Controlled particle size range matching the dimensions of natural enamel crystallites (approximately 40–60 nm length). This size match maximises integration efficiency — industrial-grade HAP offers no equivalent dimensional control.
Hydroxyapatite-LC technical specification
29.5%
Maximum concentration confirmed safe for nano-hydroxyapatite in oral care products by the EU Scientific Committee on Consumer Safety (SCCS) — providing the international regulatory reference for European and export-focused formulations.
EU SCCS safety assessment
For formulation teams

What the quality gap means
in practice

Claims substantiation requires functional-grade material

A toothpaste claiming remineralisation, enamel repair, or sensitivity relief needs an active ingredient whose performance at the stated concentration is documented. General industrial HAP at the same INCI name does not carry that documentation. The regulatory dossier built on industrial-grade material cannot support the same claims as one built on cosmetic-grade.

For OEM formulators responding to brand briefs that specify claims — not just ingredient presence — the grade of HAP sourced is the decision that determines whether the brief is deliverable.

Practical implication: Ingredient qualification for a claims-carrying product starts with the supplier's quality documentation. Hydroxyapatite-LC ships with CoA, SDS, Quasi-Drug standard reference, and EU SCCS safety file as a standard documentation package.

Lot-to-lot consistency determines formulation stability

Inconsistent particle size between batches produces inconsistent sensory properties — grit perception, suspension stability, texture — and inconsistent functional performance. For a toothpaste or deodorant running at commercial scale, lot variation in the active ingredient creates quality control costs that erode the savings from cheaper raw material pricing.

Hydroxyapatite-LC's patented manufacturing process delivers controlled morphology and minimal lot variation — the minimum requirement for formulation teams managing stability testing and quality release across a commercial production run.

Practical implication: Evaluation samples and commercial supply are produced by the same patented process. The material that performs in your lab evaluation performs the same at commercial volume.

Request the full technical package

Technical data sheet, safety documentation, Quasi-Drug standard reference, EU SCCS file, and 50–100g evaluation sample — available to qualified R&D laboratories at no charge.

Request Data & Samples Explore oral care applications →